Korea
Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference
INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference.John Rim, newly appointed President and CEO, unveiled a multidimensional business plan for the company to furt...
MoneyBrain, new AI Video tech leader in contactless at CES 2021
SEOUL, South Korea, Jan. 12, 2021 /PRNewswire/ -- MoneyBrain, a market leading
AI video synthesis technology startup, takes the first step in the global
synthetic media market with showcase at CES 2021.
Mando Corporation introduced the new vision of "Freedom in Mobility" at CES 2021
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Mando unveils its new vision
based on safety and freedom, the "Freedom in Mobility", at CES 2021.
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC). Yuyu Pharma (Yuyu) established its CP team in 2016 with the help of the law firm Kim & Chang. The CP tea...
Industry leader HLDS aims Amazon US with 'Portable DVD for Multi-OS'
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Hitachi-LG Data Storage
(HLDS), the reliable market leader in the ODD industry, launched 'Portable DVD
for Multi-OS' fromJanuary 1st through Amazon US.
ICON.AI launches World's First Smart Healthcare Device to protect your health at CES 2021
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- ICON.AI unveiled the World 1 st Smart Healthcare Device during CES 2021.   World 1st Smart Healthcare Device with Alexa Built-in With just One Touch of the Detachable Health Tracker, the Smart Healthcare Device takes comprehen...
PharmAbcine announces a research collaboration with LegoChem Biosciences
DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 291 media titles]
2026-01-05 12:14Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 288 media titles]
2026-01-08 09:05Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 283 media titles]
2026-01-08 12:01Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 282 media titles]
2026-01-07 10:00